260 related articles for article (PubMed ID: 15501437)
1. Microtubule-interfering activity of parthenolide.
Miglietta A; Bozzo F; Gabriel L; Bocca C
Chem Biol Interact; 2004 Oct; 149(2-3):165-73. PubMed ID: 15501437
[TBL] [Abstract][Full Text] [Related]
2. Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro.
Lesiak K; Koprowska K; Zalesna I; Nejc D; Düchler M; Czyz M
Melanoma Res; 2010 Feb; 20(1):21-34. PubMed ID: 19949351
[TBL] [Abstract][Full Text] [Related]
3. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells.
Kowalski RJ; Giannakakou P; Gunasekera SP; Longley RE; Day BW; Hamel E
Mol Pharmacol; 1997 Oct; 52(4):613-22. PubMed ID: 9380024
[TBL] [Abstract][Full Text] [Related]
4. A sesquiterpene lactone, costunolide, interacts with microtubule protein and inhibits the growth of MCF-7 cells.
Bocca C; Gabriel L; Bozzo F; Miglietta A
Chem Biol Interact; 2004 Jan; 147(1):79-86. PubMed ID: 14726154
[TBL] [Abstract][Full Text] [Related]
5. Antimicrotubular and cytotoxic activity of geiparvarin analogues, alone and in combination with paclitaxel.
Miglietta A; Bocca C; Gabriel L; Rampa A; Bisi A; Valenti P
Cell Biochem Funct; 2001 Sep; 19(3):181-9. PubMed ID: 11494307
[TBL] [Abstract][Full Text] [Related]
6. Parthenolide inhibits tubulin carboxypeptidase activity.
Fonrose X; Ausseil F; Soleilhac E; Masson V; David B; Pouny I; Cintrat JC; Rousseau B; Barette C; Massiot G; Lafanechère L
Cancer Res; 2007 Apr; 67(7):3371-8. PubMed ID: 17409447
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory activity of parthenolide-depleted Feverfew (Tanacetum parthenium).
Sur R; Martin K; Liebel F; Lyte P; Shapiro S; Southall M
Inflammopharmacology; 2009 Feb; 17(1):42-9. PubMed ID: 19112586
[TBL] [Abstract][Full Text] [Related]
8. Identification of tubulin as the molecular target of proapoptotic pyrrolo-1,5-benzoxazepines.
Mulligan JM; Greene LM; Cloonan S; Mc Gee MM; Onnis V; Campiani G; Fattorusso C; Lawler M; Williams DC; Zisterer DM
Mol Pharmacol; 2006 Jul; 70(1):60-70. PubMed ID: 16571652
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic and antitumoral activity of phenyl-3-(2-chloroethyl)ureas: a class of soft alkylating agents disrupting microtubules that are unaffected by cell adhesion-mediated drug resistance.
Petitclerc E; Deschesnes RG; Côté MF; Marquis C; Janvier R; Lacroix J; Miot-Noirault E; Legault J; Mounetou E; Madelmont JC; C -Gaudreault R
Cancer Res; 2004 Jul; 64(13):4654-63. PubMed ID: 15231678
[TBL] [Abstract][Full Text] [Related]
10. Molecular cytology of microtubules.
Maccioni RB
Revis Biol Celular; 1986; 8():1-124. PubMed ID: 2892233
[No Abstract] [Full Text] [Related]
11. Potential antagonism of tubulin-binding anticancer agents in combination therapies.
Taraboletti G; Micheletti G; Dossi R; Borsotti P; Martinelli M; Fiordaliso F; Ryan AJ; Giavazzi R
Clin Cancer Res; 2005 Apr; 11(7):2720-6. PubMed ID: 15814654
[TBL] [Abstract][Full Text] [Related]
12. Microtubule-binding protein CLIP-170 is a mediator of paclitaxel sensitivity.
Sun X; Li D; Yang Y; Ren Y; Li J; Wang Z; Dong B; Liu M; Zhou J
J Pathol; 2012 Mar; 226(4):666-73. PubMed ID: 21989536
[TBL] [Abstract][Full Text] [Related]
13. Parthenolide: from plant shoots to cancer roots.
Ghantous A; Sinjab A; Herceg Z; Darwiche N
Drug Discov Today; 2013 Sep; 18(17-18):894-905. PubMed ID: 23688583
[TBL] [Abstract][Full Text] [Related]
14. Laulimalide and paclitaxel: a comparison of their effects on tubulin assembly and their synergistic action when present simultaneously.
Gapud EJ; Bai R; Ghosh AK; Hamel E
Mol Pharmacol; 2004 Jul; 66(1):113-21. PubMed ID: 15213302
[TBL] [Abstract][Full Text] [Related]
15. Nordihydroguaiaretic acid, of a new family of microtubule-stabilizing agents, shows effects differentiated from paclitaxel.
Nakamura M; Nakazawa J; Usui T; Osada H; Kono Y; Takatsuki A
Biosci Biotechnol Biochem; 2003 Jan; 67(1):151-7. PubMed ID: 12619686
[TBL] [Abstract][Full Text] [Related]
16. Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest.
Kamath K; Jordan MA
Cancer Res; 2003 Sep; 63(18):6026-31. PubMed ID: 14522931
[TBL] [Abstract][Full Text] [Related]
17. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin.
Madiraju C; Edler MC; Hamel E; Raccor BS; Balachandran R; Zhu G; Giuliano KA; Vogt A; Shin Y; Fournier JH; Fukui Y; Brückner AM; Curran DP; Day BW
Biochemistry; 2005 Nov; 44(45):15053-63. PubMed ID: 16274252
[TBL] [Abstract][Full Text] [Related]
18. Effect of parthenolide on growth and apoptosis regulatory genes of human cancer cell lines.
Al-Fatlawi AA; Al-Fatlawi AA; Irshad M; Rahisuddin ; Ahmad A
Pharm Biol; 2015 Jan; 53(1):104-9. PubMed ID: 25289524
[TBL] [Abstract][Full Text] [Related]
19. Characterization of nuclear betaII-tubulin in tumor cells: a possible novel target for taxol.
Xu K; Ludueña RF
Cell Motil Cytoskeleton; 2002 Sep; 53(1):39-52. PubMed ID: 12211114
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo studies of a novel potential anticancer agent of isochaihulactone on human lung cancer A549 cells.
Chen YL; Lin SZ; Chang JY; Cheng YL; Tsai NM; Chen SP; Chang WL; Harn HJ
Biochem Pharmacol; 2006 Jul; 72(3):308-19. PubMed ID: 16782069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
